Come up with a name for your new list and we'll add to it:
Cognition Therapeutics raised a round of funding on July 18, 2008. Investors include
Pittsburgh Life Sciences Greenhouse.
Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and othe…